XML 51 R17.htm IDEA: XBRL DOCUMENT v2.4.0.6
Note 12 - Warrant Liabilities
3 Months Ended
Jun. 30, 2012
Note 12 - Warrant Liabilities:  
Note 12 - Warrant Liabilities

NOTE 12 – WARRANT LIABILITIES

 

In March and June 2010, the Company issued 4,200,000 shares of common stock and Warrants to purchase 4,000,000 shares of Common Stock (Series B warrants) to three accredited institutional funds and an accredited investor for $2,000,000.

 

The exercise price of the Series B Warrants is subject to adjustments in certain circumstances for stock splits, combinations, dividends and distributions, reclassification, exchange or substitution, reorganization, merger, consolidation or sales of assets, issuance of additional shares of common stock or equivalents.   As a result of its interpretation, the Company concluded  that the Series B Warrants and Option to purchase additional common stock and Series B Warrants should be treated as derivative liabilities because the warrants are entitled to a price adjustment provision to allow the exercise price to be reduced in the event the Company issues or sells any additional shares of common stock at a price per share less than the then-applicable exercise price or without consideration, which is typically referred to as a “down-round protection” or “anti-dilution” provision.  The Company uses Level 2 inputs to measure fair value of its warrant liability.

 

During the nine months ended June 30, 2012, the Company's warrant liabilities accounts were as follows: 

 

 

Opening balance, October 1, 2011

$

1,545,098

Issued in nine months ended June 30, 2012

-

Change in warrant liabilities

 

(1,010,776)

Exercised in nine months ended June 30, 2012

-

Closing balance, June 30, 2012

$

534,322

 

 

 

The following table summarizes the shares of the Company's common stock issuable upon exercise of warrants outstanding at June 30, 2012:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding

 

 

Warrants Exercisable

 

 

Range of

Exercise

Price

 

 

Number of shares underling warrants

Outstanding at

June 30, 2012

 

 

Weighted

Average

Remaining

Contractual

Life (Years)

 

 

Weighted

Average

Exercise

Price

Number of shares underling warrants

Exercisable at

June 30, 2012

 

 

Weighted

Average

Exercise

Price

 

 

 

$

0.70

 

 

 

2,000,000

 

 

 

0.73

 

 

$

0.70

 

 

 

2,000,000

 

 

$

0.70

 

 

 

 

$

1.00

 

 

 

2,000,000

 

 

 

0.94

 

 

 

1.00

 

 

 

2,000,000

 

 

 

1.00

 

 

 

 

 

  

 

 

 

4,000,000

 

 

 

0.83

 

 

$

0.85

 

 

 

4,000,000

 

 

$

0.85